In 2012, from the entrepreneurial initiative of a group of experts from companies operating in the health sector and, from the request of numerous specialists in the oncology sector, a passionate team of doctors and engineers was born to promote the practice of oncological hyperthermia as a therapy for fight cancer.
The team has direct experience with oncological hyperthermia as a cancer cure and has directly gained awareness of the promising results of the therapy. The final goal of the Andromedic team is to spread the use of hyperthermia as adjuvant and neoadjuvant to classic treatments (Surgery, Chemotherapy,
Radiotherapy) for the treatment of cancer and, finally, to consolidate the hyperthermia as a fourth pillar for cancer treatment.
The team firmly believes in the effectiveness of the method, which may increase survival, while improving general well-being and providing relief in the control of painful symptoms to cancer patients.
Company’s Keywords:
<0
<
<
<